| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |